(Q33388537)

26 July 2017

Assessment of the feasibility of exon 45-55 multiexon skipping for Duchenne muscular dystrophy (English)

1 reference

Duchenne muscular dystrophy

26 July 2017

1 reference

inferred from title

author

Annemieke Aartsma-Rus

5

object named as

Annemieke Aartsma-Rus

0 references

Gert-Jan van Ommen

4

object named as

Gert-Jan B van Ommen

0 references

author name string

Laura van Vliet

1

1 reference

26 July 2017

Christa L de Winter

2

1 reference

26 July 2017

Judith C T van Deutekom

3

1 reference

26 July 2017

1 December 2008

1 reference

26 July 2017

1 reference

26 July 2017

9

1 reference

26 July 2017

105

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2350-9-105

26 July 2017

0 references

cites work

Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611974

Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611974

Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611974

Induction of revertant fibres in the mdx mouse using antisense oligonucleotides

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611974

Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sites

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611974

Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611974

Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611974

Advances in Duchenne muscular dystrophy gene therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611974

Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611974

The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611974

Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-9-105

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-9-105

Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-9-105

Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-9-105

Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2350-9-105

Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19046429

12 December 2020

inferred from PubMed ID database lookup

Local dystrophin restoration with antisense oligonucleotide PRO051

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19046429

12 December 2020

inferred from PubMed ID database lookup

Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19046429

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/1471-2350-9-105

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference